Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: Systematic review and meta-analysis

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Amick, Halle R ^a   Gartlehner, Gerald ^b,c   Gaynes, Bradley N ^d   Forneris, Catherine ^d   Asher, Gary N ^d   Morgan, Laura C ^b   Coker Schwimmer, Emmanuel ^a   Boland, Erin ^b   Lux, Linda J ^b   Gaylord, Susan ^d   Bann, Carla ^b   Pierl, Christiane Barbara ^c   Lohr, Kathleen N ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b RTI INTERNATIONAL   (United States)

^c DANUBE UNIVERSITY KREMS   (Austria)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REMISSION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYSTEMATIC REVIEW; DEPRESSIVE DISORDER, MAJOR; PROCEDURES;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS;

EID: 84959017592     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h6019     Document Type: Article

References (50)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
2. Wang PS, Lane M, Olfson M, et al. Twelve-month use of mental health services in the United States: Results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:629-40.
3. American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. APA, 2010.
4. Qaseem A, Snow V, Denberg TD, et al. Using second-generation antidepressants to treat depressive disorders: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2008;149:725-33.
5. Institute of Medicine. Crossing the quality chasm: A new health system for the 21st century. National Academies Press, 2001.
6. Mojtabai R, Olfson M. National trends in long-term use of antidepressant medications: Results from the U.S. National Health and Nutrition Examination Survey. J Clin Psychiatry 2014;75:169-77.
7. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Ann Intern Med 2011;155:772-85.
8. Xing S, Dipaula BA, Lee HY, et al. Failure to fill electronically prescribed antidepressant medications: A retrospective study. Prim Care Companion CNS Disord 2011;13:pii: PCC.10m00998.
9. Gartlehner G, Thieda P, Hansen RA, et al. Comparative risk for harms of second-generation antidepressants: A systematic review and meta-analysis. Drug Saf 2008;31:851-65.
10. McHugh RK, Whitton SW, Peckham AD, et al. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: A meta-analytic review. J Clin Psychiatry 2013;74:595-602.
11. Raue PJ, Schulberg HC, Heo M, et al. Patients' depression treatment preferences and initiation, adherence, and outcome: A randomized primary care study. Psychiatr Serv 2009;60:337-43.
12. Churchill R, Khaira M, Gretton V, et al. Treating depression in general practice: Factors affecting patients' treatment preferences. Br J Gen Pract 2000;50:905-6.
13. Dwight-Johnson M, Sherbourne CD, Liao D, et al. Treatment preferences among depressed primary care patients. J Gen Intern Med 2000;15:527-34.
14. Brody DS, Khaliq AA, Thompson TL 2nd. Patients' perspectives on the management of emotional distress in primary care settings. J Gen Intern Med 1997;12:403-6.
15. Morey E, Thacher JA, Craighead WE. Patient preferences for depression treatment programs and willingness to pay for treatment. J Ment Health Policy Econ 2007;10:73-85.
16. Priest RG, Vize C, Roberts A, et al. Lay people's attitudes to treatment of depression: Results of opinion poll for Defeat Depression Campaign just before its launch. BMJ 1996;313:858-9.
17. Van Schaik DJ, Klijn AF, Van Hout HP, et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004;26:184-9.
18. Wittink MN, Cary M, Tenhave T, et al. Towards patient-centered care for depression: Conjoint methods to tailor treatment based on preferences. Patient 2010;3:145-57.
19. Cooper LA, Gonzales JJ, Gallo JJ, et al. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care 2003;41:479-89.
20. Givens JL, Houston TK, Van Voorhees BW, et al. Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry 2007;29:182-91.
21. Mergl R, Henkel V, Allgaier AK, et al. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm. Psychother Psychosom 2011;80:39-47.
22. Cuijpers P, Van Straten A, Andersson G, et al. Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008;76:909-22.
23. Nieuwsma JA, Trivedi RB, McDuffie J, et al. Brief psychotherapy for depression: A systematic review and meta-analysis. Int J Psychiatry Med 2012;43:129-51.
24. American Psychological Association. Recognition of psychotherapy effectiveness. 2012. www.apa.org/about/policy/resolutionpsychotherapy. aspx.
25. Spielmans GI, Berman MI, Usitalo AN. Psychotherapy versus second-generation antidepressants in the treatment of depression: A meta-analysis. J Nerv Ment Dis 2011;199:142-9.
26. Gartlehner G, Gaynes B, Amick H, et al. Nonpharmacological versus pharmacological treatments for adult patients with major depressive disorder. Agency for Healthcare Research and Quality, 2015 (Comparative Effectiveness Review No 161). www.effectivehealthcare. ahrq.gov/reports/final.cfm.
27. Cochrane Depression, Anxiety and Neurosis Group. CCDAN topic list: Intervention-psychological therapies. 2013. http://cmd.cochrane. org/sites/cmd.cochrane.org/files/uploads/CCDAN%20topics%20 list-psychological%20therapies%20for%20website-0.pdf.
28. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials. BMJ 2011;343:d5928.
29. Berkman ND, Lohr KN, Ansari MT, et al. Grading the strength of a body of evidence when assessing health care interventions: An EPC update. J Clin Epidemiol 2015;68:1312-24.
30. McGrath CL, Kelley ME, Holtzheimer PE, et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry 2013;70:821-9.
31. Sava FA, Yates BT, Lupu V, et al. Cost-effectiveness and cost-utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (Prozac) in treating depression: A randomized clinical trial. J Clin Psychol 2009;65:36-52.
32. David D, Szentagotai A, Lupu V, et al. Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: A randomized clinical trial, posttreatment outcomes, and six-month follow-up. J Clin Psychol 2008;64:728-46.
33. Kennedy SH, Konarski JZ, Segal ZV, et al. Differences in brain glucose metabolism between responders to cognitive behavioral therapy and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 2007;164:778-88.
34. Leykin Y, Amsterdam JD, DeRubeis RJ, et al. Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. J Consult Clin Psychol 2007;75:267-76.
35. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006;74:658-70.
36. Segal ZV, Kennedy S, Gemar M, et al. Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Arch Gen Psychiatry 2006;63:749-55.
37. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409-16.
38. Miranda J, Chung JY, Green BL, et al. Treating depression in predominantly low-income young minority women: A randomized controlled trial. JAMA 2003;290:57-65.
39. Mynors-Wallis LM, Gath DH, Day A, et al. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000;32:26-30.
40. Hegerl U, Hautzinger M, Mergl R, et al. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: A randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010;13:31-44.
41. Landenberger NAD. Self-concept and attributional style in the treatment of depression. ProQuest Information and Learning, 2002.
42. Lam RW, Parikh SV, Ramasubbu R, et al. Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. Br J Psychiatry 2013;203:358-65.
43. Shamsaei F, Rahimi A, Zarabian MK, et al. Efficacy of pharmacotherapy and cognitive therapy, alone and in combination in major depressive disorder. Hong Kong J Psychiatr 2008;18:76-80.
44. Berkman ND, Lohr KN, Ansari M, et al. Grading the strength of a body of evidence when assessing health care interventions for the effective health care program of the agency for healthcare research and quality: An update. 2103. In: Methods guide for effectiveness and comparative effectiveness reviews [Internet]. Agency for Healthcare Research and Quality (US), 2008 (available at www.ncbi.nlm.nih.gov/books/NBK174881/).
45. Dobson KS, Hollon SD, Dimidjian S, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol 2008;76:468-77.
46. Cuijpers P, Berking M, Andersson G, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry 2013;58:376-85.
47. Cuijpers P, Sijbrandij M, Koole SL, et al. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: A meta-analysis of direct comparisons. World Psychiatry 2013;12:137-48.
48. Cuijpers P, Sijbrandij M, Koole SL, et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: A meta-analysis. World Psychiatry 2014;13:56-67.
49. Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for management of major depressive disorder (major depressive disorder). Department of Veterans Affairs, Department of Defense, 2009.
50. National Institute for Health and Care Excellence (NICE). Depression in adults: Recognition and management.NICE, 2009 (clinical guideline CG90) (available from www.nice.org.uk/guidance/cg90).